|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/28 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 31/472 | (2006.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 3003284 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14735770.1 |
| Date of filing the European patent application | 2014-06-05 | |
| (97) | Date of publication of the European application | 2016-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation | 2020-04-27 |
| (86) | Number | PCT/US2014/041021 |
| Date | 2014-06-05 |
| (87) | Number | WO 2014/197660 |
| Date | 2014-12-11 |
| (30) | Number | Date | Country code |
| 201361831909 P | 2013-06-06 | US |
| (72) |
CONCA, David, US
FLIPPIN, Lee, Allen, US
LEIGH, Scott, David, US
WITSCHI, Claudia, US
WRIGHT, Lee, Robert, US
|
| (73) |
Fibrogen, Inc.,
409 Illinois Street, San Francisco, CA 94158,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | HIF hidroksilazės inhibitoriaus farmacinės kompozicijos |
| PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-05-21 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-01-23 |